Loblaw Q2 2025 presentation slides: Revenue up 5.2%, adjusted EPS grows 11.6%

Loblaw Companies Limited reported robust Q2 2025 results, with consolidated revenue increasing 5.2% to $14.67 billion and adjusted diluted EPS rising 11.6% to $2.40, driven by strong performance across both its food and drug retail segments. The Canadian retailer saw food retail same-store sales grow 3.5% and drug retail same-store sales increase 4.1%, while also improving free cash flow and reducing capital expenditures. Strategic initiatives include digital innovation, AI integration, and exploring U.S. expansion with its T&T brand, alongside a planned 4-for-1 stock split, all contributing to a 1% stock increase post-earnings and reinforcing management's confidence in its full-year outlook and market leadership.

Analysis

Loblaw Companies Limited (TSX:L) delivered strong Q2 2025 results, with consolidated revenue increasing 5.2% to $14.672 billion and adjusted diluted EPS rising 11.6% to $2.40. This robust performance was underpinned by growth across both food retail (5.8% revenue increase) and drug retail (4.3% revenue increase), demonstrating resilience in a challenging market. Adjusted EBITDA also grew 7.4%, with margin expansion of 20 basis points to 12.5%.

The company exhibited improved operational efficiency, evidenced by a 10 basis point improvement in the adjusted retail SG&A rate to 19.8% and stable retail gross margins at 32.0%. Free cash flow improved to $468 million, while net capital expenditure significantly decreased to $239 million, indicating disciplined capital allocation. These efficiencies contributed to the outperformance of EPS growth relative to revenue.

Operational momentum was strong, with food retail same-store sales up 3.5% and drug retail same-store sales up 4.1%, notably driven by pharmacy services (6.2% growth). Strategic initiatives, including digital innovation, AI integration, and a planned 4-for-1 stock split effective August 18, 2025, underscore management's confidence in future growth prospects. The stock closed up 1% at CAD 55.19 post-earnings, reflecting positive investor reception.

Loblaw is also exploring U.S. expansion with its T&T brand, potentially diversifying growth avenues beyond Canadian market saturation, while leveraging its discount formats to navigate consumer price sensitivity. The company remains confident in its full-year outlook, despite facing challenges like supply chain disruptions.

Key Decisions for Investors

• Monitor the impact of the 4-for-1 stock split on liquidity and investor accessibility, as it signals management's positive long-term outlook.
• Evaluate the progress of Loblaw's AI-driven initiatives and potential U.S. expansion with the T&T brand for sustained growth drivers beyond its mature Canadian market.
• Assess the company's continued ability to manage cost efficiencies and maintain stable margins amidst consumer price sensitivity and potential supply chain disruptions.